Serologic testing for celiac disease in young adults - A cost-effect analysis

Digestive Diseases and Sciences

Volumn 50, Issue 4, 2005, Pages 796-805

  Yagil, Yael ^a   Goldenberg, Ilan ^a   Arnon, Ronen ^a   Ezra, Vered ^a,b   Ashkenazi, Isaac ^c  

^a MEDICAL CORPS   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Celiac; Cost effect; Serologies

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; ARMY; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEALTH CARE POLICY; HUMAN; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; SERODIAGNOSIS;

ADULT; ALGORITHMS; AUTOANTIBODIES; CELIAC DISEASE; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FEMALE; GLIADIN; HEALTH CARE COSTS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MASS SCREENING; MILITARY PERSONNEL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TRANSGLUTAMINASES;

EID: 17644420693     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2576-y     Document Type: Article

References (16)

1. Farrell RJ, Kelly CP: Celiac sprue. N Engl J Med 346(3):180-188, 2002
2. Fasano A, Catassi C: Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 120:636-651, 2001
3. McPherson RA: Commentary: advances in the laboratory diagnosis of celiac disease. J Clin Lab Anal 15:105-107, 2001 (abstr)
4. McManus R, Kelleher D: Celiac disease - the villain unmasked? N Engl J Med 348(25):2573-2574, 2003
5. Isselbacher KJ: Celiac disease: Often underdiagnosed and clinically silent. www.harrisonsonline.com, 2001-2003 (McGraw-Hill)
6. Pruessner TH: Detecting celiac disease in your patients. www.aafp.org, 1998 (American Academy of Family Physicians)
7. Kelly CP: Use of serum antibodies to diagnose celiac disease. www.uptodate.com, 2003 (UpToDate)
8. Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JWR, Mulder CJJ: Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice. Am J Gastroenterol 94:888-894, 1999
9. Johnston SD, Watson RGP, McMillan SA, et al.: Coeliac disease detected by screening is not silent - simply unrecognized. Q J Med 91:853-860, 1998
10. Shamir R, Lerner A, Shinar E, et al.: The use of a single serological marker underestimates the prevalence of celiac disease in Israel: A study of blood donors. Am J Gastroenterol 97:2589-2594, 2002
11. Gomez JC, Selvaggio G, Pizzaro B, et al.: Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. Am J Gastroenterol 97:2785-2790, 2002
12. Corrao G, Corazza GR, Andeani ML, et al.: Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut 35:771-775, 1994
13. Harewood GC, Murray J: Diagnostic approach to a patient with suspected celiac disease - A cost analysis. Dig Dis Sci 46:2510-2514, 2001
14. Ferreira M, Davies S, Butler M, et al.: Endomysial antibody: Is it the best screening test for celiac disease? Gut 33:1633-1637, 1992
15. Weiss B, Bujanover Y, Avidan B, Fradkin A, Weintraub I, Shainberg B: Positive tissue transglutaminase antibodies with negative endomysial antibodies: Low rate of celiac disease. IMAJ 6:9-12, 2004
16. Clemente MG, Musu MP, Frau F, Lucia C, De Virgiliis S: Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr 34(1):31-34, 2002